During the past decade, Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute" #1 collaborator was "Childhood Asthma in Urban Settings (CAUSE)" with 1 trials as a collaborator, "Regeneron Pharmaceuticals" with 1 trials as a collaborator and "Rho Federal Systems Division, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute" are "Asthma" (2 trials). Many other conditions were trialed in "Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute" in a lesser frequency.

Most popular intervention types in "Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dupilumab" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".